nomilin has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuttan, G; Pratheeshkumar, P; Raphael, TJ | 1 |
1 other study(ies) available for nomilin and Neoplasm Metastasis
Article | Year |
---|---|
Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells.
Topics: Activating Transcription Factor 2; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Benzoxepins; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; DNA Fragmentation; Down-Regulation; Limonins; Lung Neoplasms; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Transcription Factors; Tumor Suppressor Protein p53; Up-Regulation | 2012 |